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Abstract
Background: Our interest in chronic conditions is due to the fact that, worldwide, chronic diseases have overtaken
infectious diseases as the leading cause of death and disability, so their management represents an important challenge for
health systems. The aim of this study was to compare the performance of primary health care services in managing
diabetes, congestive heart failure (CHF) and coronary heart disease (CHD), by age group.
Methods: This population-based retrospective cohort study was conducted in Italy, enrolling 1,948,622 residents $16 years
old. A multilevel regression model was applied to analyze compliance to care processes with explanatory variables at both
patient and district level, using age group as an independent variable, and adjusting for sex, citizenship, disease duration,
and Charlson index on the first level, and for District Health Unit on the second level.
Results: The quality of chronic disease management showed an inverted U-shaped relationship with age. In particular, our
findings indicate lower levels for young adults (16–44 year-olds), adults (45–64), and oldest old (+85) than for patients aged
65–74 in almost all quality indicators of CHD, CHF and diabetes management. Young adults (16–44 y), adults (45–64 y), the
very old (75–84 y) and the oldest old (+85 y) patients with CHD, CHF and diabetes are less likely than 65–74 year-old
patients to be monitored and treated using evidence-based therapies, with the exceptions of echocardiographic monitoring
for CHF in young adult patients, and renal monitoring for CHF and diabetes in the very old.
Conclusion: Our study shows that more effort is needed to ensure that primary health care systems are sensitive to chronic
conditions in the young and in the very elderly.
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Background
The rising prevalence of chronic diseases all over the world is a
growing cause of concern in the public health sector. Worldwide,
chronic diseases have overtaken infectious diseases as the leading
cause of death and disability. Non-communicable diseases now
account for 63% of the world’s annual deaths, and approximately
half of the global burden of disease [1]. Efforts have been made to
identify strategies to prevent or reduce the risk of chronic diseases,
as well as to organize an appropriate secondary prevention and
management of chronic diseases to reduce the associated
complications. There is currently a growing interest in the
developed countries in redesigning health care organizations [2],
focusing on practices to improve the quality of care and guarantee
an equitable, timely and effective management of chronic diseases
[3].
Disease management programs include measuring processes
and outcomes [4]. Carefully designed, evidence-based care
processes, sustained by automated clinical information and
decision support systems, offer the highest chances of achieving
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the best outcomes from care provided for chronic conditions [5].
Clinical process indicators for assessing the medical management
of chronic diseases are widely used for the purposes of producing
evidence of the quality of care, and they can also be used to test
whether an equitable service is offered to the different socioeco-
nomic strata in the population. It is generally recognized that
health care inequalities exist, which may be classifiable using
socioeconomic measures, or by ethnic group or gender [6], but it is
important to consider whether such inequalities exist for different
age groups too. Some studies, for example, have identified an
‘‘under-prescription’’ phenomenon for the chronically ill among
the oldest old [7], and this also relates to cases of coronary heart
disease (CHD) [8]. The differences identified could represent an
excellent starting point for efforts to better define optimum care or
best practices, to design care processes that meet patients’ needs
[3], and to improve the quality of primary health care in terms of
an equitable management of chronic diseases. With this in mind, it
becomes essential to consider health system performance indica-
tors also in terms of the different age groups comprising the
population [9].
The aim of the present study conducted in Italy was to ascertain
whether adherence to disease management guidelines is the same
in all age groups of patients with diabetes, congestive heart failure
(CHF) or CHD.
Methods
Italy is divided administratively into 20 regions, and each
regional government is responsible for fulfilling the objectives of
the National Health Plan in its area. These regional authorities
plan and organize health care facilities and activities through their
regional health departments. They also coordinate and control
local health units (LHU), each of which is a single National Health
Service (NHS) unit that plans and delivers health care services to
its local community. Each LHU is organized into geographical
subareas called Health Districts (HD), which manage all the local
primary health care structures and community services.
In Italy, all citizens are registered with a freely-chosen general
practitioner (GP), and these GPs have a gate-keeping role. There
are established drug prescriptions, exemptions from prescription
charges, and diagnostic tests specific for a given chronic condition
for patients with certain chronic diseases, as listed in a Decree of
the Ministry of Health approved in 1999. To obtain drugs and
diagnostic tests free of charge, patients need to exhibit their GP’s
prescription.
Data and Variables
Six Italian regions, two in northern Italy (Lombardy and
Veneto), three in central Italy (Emilia Romagna, Tuscany and
Marche), and one in southern Italy (Sicily) took part in the
VALORE project, an initiative of the National Agency for
Regional Health Systems for the purpose of assessing quality of
care for chronic diseases and the organization of primary health
care services [10]. The present study was an offshoot of this
project. One or two LHUs from each region were involved (8 in
all), and 2–4 HDs for each LHU (amounting to 21 in all), which
shared their data (each regional authority independently chose
which LHUs and HDs to enroll in the study). The dataset used in
our analysis was generated by automatically processing adminis-
trative records. The following data files were used: a) hospital
discharge records with one main and five secondary diagnoses
coded using the International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD9CM); b) drug dispensing
records coded using the Anatomical Therapeutic Chemical (ATC)
codes for drug classification (the ATC system is the drug
classification system adopted by the World Health Organization),
excluding drugs administered in hospital; c) disease-specific
exemptions from copayment for health care, coded using the
ICD9CM; d) the population registry with demographic details
(year of birth, gender); and e) the outpatient care database
(recording visits to doctors, blood tests or other diagnostic
examinations). In each region, record-linkage within and between
data files was done deterministically using a unique, coded
personal identifier. The number of individuals aged 16 years or
more as at 1 January 2008 amounted to 1,948,622; the cases of
diabetes, CHD or CHF were identified by means of algorithms
developed by the Tuscany Regional Public Health Agency, based
either on the diagnoses reported in the hospital discharge records
or on disease-specific drug dispensing records or disease-specific
health care copayment exemptions [11]. This procedure led us to
identify 105,987 patients with diabetes, 86,725 with CHD, and
Table 1. Sample characteristics.
CHD % (n) CHF % (n) DIABETES % (n)
Sex Male 56.7% (46,255) 49.6% (12,394) 51.6% (52,760)
Age group 16–44 yrs 1.2% (947) 1.2% (303) 5.2% (5,332)
45–64 yrs 16.6% (13,570) 11.1% (2,765) 27.6% (28,182)
65–74 yrs 24.8% (20,201) 19.6% (4,891) 29.9% (30,586)
75–84 yrs 35.6% (29,989) 37.8% (9,442) 27.4% (27,988)
85+ yrs 21.9% (17,835) 30.4% (7,596) 9.9% (10,119)
Citizenship Italian 98.8% (76,056) 98.9% (23,544) 96.9% (93,550)
HDC 0.2% (186) 0.3% (62) 0.3% (283)
HMPC 0.9% (714) 0.8% (199) 2.8% (2,696)
Charlson index no comorbidity 56.7% (46,218) 26,8% (6,705) 68.6% (70,080)
low comorbidity 19.6% (15,994 25.1% (6,267) 13.5% (13,829)
high comorbidity 23.7% (19,330) 48.1% (12,025) 17.9% (18,298)
Time since diagnosis more than 3 yrs 63.1% (51,467) 42.4% (10,592) 66.0% (67,461)
doi:10.1371/journal.pone.0091340.t001
Chronic Disease Management by Age Class
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28,062 with CHF, who formed the initial sample of patients
considered in this study.
Process indicators for the purpose of assessing what health care
providers did for their patients and how well they did so [12] were
chosen among those identified and defined by scientific associa-
tions as quality measures of interest for improving outcomes for
outpatients. In particular, for the diabetics we measured three
indicators that the OECD considers indicative of the quality of
care for diabetes at health system level [13], i.e. annual HbA1c
testing; annual screening for nephropathy; annual LDL cholesterol
testing. These indicators were calculated in terms of: the
percentage of patients who had one or more HbA1c test a year;
the percentage of patients who had at least one micro-albuminuria
test during the year considered; the percentage of patients who
had at least one annual LDL cholesterol test.
For cases of CHD, we measured three indicators that the
Chronic Stable Coronary Artery Disease Work Group [14]
considers indicative of the quality of care for CHD with a view
to improving outcomes for outpatients with chronic stable
coronary artery disease, i.e. therapy with angiotensin-converting
enzyme (ACE) inhibitors; therapy with anti-thrombotic agents;
and annual total cholesterol monitoring. These indicators were
calculated in terms of: the percentage of patients who had at least
two prescriptions of ACE inhibitors in the same year, separated by
an interval of at least 180 days; the percentage of patients with at
least two prescriptions of anti-thrombotic agents, separated by an
interval of at least 180 days; the percentage of patients with at least
one total cholesterol test a year.
For patients with CHF, we chose four indicators that the Heart
Failure Work Group [15] considers indicative of the quality of care
for CHF in terms of improving outcomes for outpatients with
heart failure, i.e. therapy with ACE inhibitors; therapy with beta-
blockers; 6-monthly monitoring of creatinine, Na and K; and
annual echocardiography. These indicators were calculated in
terms of: the percentage of patients with at least two prescriptions
of ACE inhibitors in a year, separated by an interval of at least 180
days; the percentage of patients with at least two prescriptions of
beta-blockers, separated by an interval of at least 180 days; the
percentage of patients with at least one creatinine, Na and K test
in the previous six months; and the percentage of patients
completing at least one echocardiogram a year. These indicators
were computed during a one-year follow-up (1 January 2009 to 31
December 2009) by linking the three pathology cohorts of patients
to the administrative databases recording prescriptions for drug
dispensing and diagnostic tests. To overcome any selection bias
that might undermine the validity of our results we excluded all
patients lost to follow-up because this loss is associated in our
database with both exposure (age group) and outcome (adherence
to the process indicator). The analyses were performed on 102,207
diabetic patients, 81,542 CHD and 24,997 CHF patients.
We only enrolled people registered with the Italian NHS (all
Italian citizens and regular immigrants, i.e. foreigners who have a
regular entry visa or residence permit) and we classified nationality
as follows: Italians; immigrants from highly-developed countries
(HDC); and immigrants from high migratory pressure countries
(HMPC) [16].
The Charlson index was calculated to assess patients’ comor-
bidities: this index has proved a valid and reliable method for
measuring comorbidities for the purpose of clinical research and,
although it was first developed and validated for hospitalized
patients, it has since been adapted and validated for primary care
and community populations too [17].
Figure 1. OR and 95%CI of multilevel logistic adjusted
regressions in CHD patients: dependent variable= compliance
with disease management standards; independent variable=
age group.
doi:10.1371/journal.pone.0091340.g001
Chronic Disease Management by Age Class
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Statistical Methods
The data were summarized as numbers (percentages) of subjects
for categorical variables. The chi-square statistic was used to test
the hypothesis of independence between age group and adherence
to standards of care. A multilevel logistic regression model was
applied to analyze the association between age group and
compliance with standards of care. The data had a hierarchical
structure, with the patient on the first level and the HD on the
second level. The dependent variables were analyzed in dichot-
omous form (yes/no) for each patient’s compliance with evidence-
based quality of care requirements for the management of the
diseases considered. In addition to the independent dummy
variable age group (reference age group 65–74 y), the covariates in
the regression model were: gender, nationality, time since
diagnosis (dichotomized as #3 y and .3 y), and Charlson index
on the first level, and HD on the second. A multilevel logistic
regression model was also applied, similar to the one previously
described except that age group (16–44, 45–64, 65–74, 75–84,
.85 years old) was included in the model as an independent
categorical variable, and also a quadratic term was used for the
age group variable (enabling us to verify the hypothesized U-
shaped curve).
Individuals whose citizenship was not known were excluded
from the regression analysis (this applied to 5.6% of the diabetics
and CHD patients, and to 4.78% of the CHF patients), so the
multilevel regression analyses were performed on 96,529 patients
with diabetes, 76954 with CHD, and 23,805 with CHF.
Data were analyzed using STATA software version 12.
Ethics Statement
The study complied with the Declaration of Helsinki and with
Italian Law (Decree n. 196/2003) on the protection of personal
data. Resolution n. 85/2012 of the Guarantor for the protection of
personal data also recently confirmed that it is allowable to process
personal data for medical, biomedical and epidemiological
research purposes, and data concerning health status can be used
in aggregate form in scientific studies [18]. No identifiable human
data were used for this study. The dataset used in the study is not
publicly available. Permission to use non-identifiable individual
data extracted from administrative databases for the VALORE
project was granted by the ULSS 16 Padova, the ASP 7 Ragusa,
the Assessorato Politiche per la Salute Emilia Romagna, the Zona
Territoriale Senigallia, the Regione Lombardia, and the Agenzia
Regionale di Sanita` della Toscana, which are responsible for any
use of the data concerning their respective populations. A
disclosure statement was also submitted to the ethics committees
of the Local Health Units in the areas participating in the study.
Approval for the use of encrypted and aggregated data was also
obtained from the Italian College of General Practitioners.
Results
The characteristics of the sample are shown in Table 1.
Table 2 shows details of the specific indicators monitored and
highlights the differences by age group. For almost all indicators,
the percentage of patients undergoing the recommended tests or
taking the evidence-based recommended therapy was lower in the
extreme age groups (i.e. the young adults and the oldest old) than
in the middle age group (65- to 74-year-olds).
The results of our multilevel logistic regressions (Figures 1, 2, 3)
systematically confirmed age-related differences in all quality
management indicators for the three chronic diseases considered,
showing an inverted U-shaped relationship with age in almost all
process indicators. Compliance with the recommended guidelines
Figure 2. OR and 95%CI of multilevel logistic adjusted
regressions in diabetic patients: dependent variable= compli-
ance with disease management standards; independent varia-
ble = age group.
doi:10.1371/journal.pone.0091340.g002
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was greater in the young elderly age group than for any of the
other age groups for almost all the indicators relating to all three
chronic diseases studied. By comparison with the young elderly
(65- to 74-year-olds), young adults (16- to 44-year-olds) with
diabetes had more than 50% lower odds of all three quality
indicators (lipids, HbA1c and creatinine) being monitored
annually; young adults with CHD had a more than 70% lower
likelihood of being treated with ACE inhibitors and anti-
thrombotic agents, and almost 70% lower odds of having their
cholesterol profile checked; and young adult CHF patients had
more than 70% lower odds of being treated with ACE inhibitors,
as well as more than 30% lower odds of being treated with beta-
blockers and having their creatinine, sodium and potassium levels
monitored annually.
Discussion
To the best of our knowledge, this is the first study to be
conducted in Europe to assess the equity of access to health
services for chronic diseases by age group. Age-related disparities
systematically emerged in patients’ compliance with the recom-
mended guidelines for the care of diabetes, coronary artery disease
and congestive heart failure, generating an inverted U-shaped
relationship with age in terms of patients’ compliance with
standards considered for these chronic conditions. In particular,
our results indicate that young adults (16- to 44-year-olds), middle-
aged adults (45- to 64-year-olds), the very old (75- to 84-year-olds),
and the oldest old (85 and over) with CHD, CHF or diabetes are
less likely to be monitored and treated according to the evidence-
based recommendations than patients aged 65 to 74, with the sole
exceptions of echocardiographic monitoring in young adult CHF
patients and renal monitoring for very old CHF and diabetic
patients. These results are alarming because an inadequate
management of chronic conditions means a worse outcome for
patients and consequently higher health care costs [19].
These findings indicate that, while the Italian population is
increasingly liable to chronic conditions, the health care delivery
system has hitherto remained poorly organized to provide care for
Figure 3. OR and 95%CI of multilevel adjusted logistic regressions in CHF patients: dependent variable = compliance with disease
management standards; independent variable= age group.
doi:10.1371/journal.pone.0091340.g003
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these patients. The picture is much the same elsewhere around the
world, where it has been reported that health care systems are not
well designed to meet the needs of the chronically ill [3]. The
current health care delivery system responds primarily to acute
and urgent health problems, with the emphasis on diagnosing a
patient’s condition, ruling out serious diseases, and relieving
symptoms. Patients with chronic conditions would be better served
by a systematic approach focusing on self-management, with a
multidisciplinary team planning their care, routine assessment and
follow-up [20]. There are possibly two main reasons for our
results, explaining why the health care delivery system succeeded
in managing the older adult (but not the very old) patients more
systematically: one is that patients in this age group more
frequently seek primary health care spontaneously; the other is
that these patients are more likely to adhere to their primary care
physicians’ recommendations for their treatment and monitoring.
The situation could also have to do with the Italian primary health
care model being based on a ‘‘waiting paradigm’’, meaning that an
event has to occur before action is taken to solve the problem.
Waiting is the classical health care paradigm of the biomedical
model, and it has also become the dominant paradigm in
territorial and primary health care [21]. Patients aged 65 to 74
could access health care services more easily because they are
more likely to be retired than younger adults, and more likely to be
able to move unassisted than older people, and therefore go to see
physicians, who ‘‘wait’’ for patients to come to them. Wagner et al
[20] made the point that successful chronic disease management
programs should: (i) produce protocols or plans that state explicitly
what needs to be done for patients, at what intervals, and by
whom, and that considers the needs of all patients with specific
clinical features, and how their needs can be met; and (ii) use
registries to inform health care providers about which patients
have certain conditions and thereby enable these patients’
proactive clinical management. Using reminder systems improves
patients’ participation in appropriate care plans. With this in
mind, one way to reduce age-related disparities in the manage-
ment of chronic conditions would be to adopt a more proactive
approach to primary health care, seeking to identify patients’
needs without waiting for them to come forward [5]. Such a model
had not been applied in Italy up until the period generating the
data analyzed in the present study, but it has since been adopted in
some Italian regions, based on an integrated chronic care model
[22,23]. Further research will be useful to see whether this can
reduce age-related inequalities in chronic disease management.
The results of our study are partly concordant with a previous
Canadian study in which older adults reported receiving better
health services for chronic disease management than the very
elderly [24]. This study assessed the family physician’s intent by
measuring prescriptions or recommendations, so the results cannot
reflect the patient’s compliance. Our study focused instead on
compliance with disease management guidelines, assessed by
means of an administrative database, so our findings could be
associated not only with the equity of care provided by physicians
(as in the Canadian study), but also with patient compliance.
Adherence is a multifaceted behavioral issue influenced by how
health care is delivered by health care providers’ practices, as well
as by patient-related factors [25]. Age has an important influence
on non-compliance with health professionals’ recommendations,
and different age groups have a different health-related behavior,
more pertinent to their needs, the amount of time they have
available, and so on [26]. Adherence to therapy and monitoring is
crucial to preventing complications in the chronically ill and, by
adopting a collaborative care model for chronic illness, health care
providers can promote their patients’ self-management with a view
to improving the chances of their disease being handled effectively
by helping patients and families to cope with self-care tasks [27].
To be most effective, health care providers should have a patient-
centered approach, cultivate a collaborative relationship, commu-
nicate clearly, provide advice when patients are ready to hear it,
and learn more about any new recommendations [28]. Several
specific strategies can help patients to change their behavior.
Effective ways to reduce their resistance include: emphasizing their
personal choice and control; reassessing their readiness, their
conviction of the importance of their actions, and their confidence
in the outcome; and sometimes backing off and supporting
patients’ own decisions [29], or supporting patients capable of
going online to obtain test results, take part in interactive care
management services, and receive after-care instructions - by
means of appropriately structured e-mail communications be-
tween patients with the same condition, for example [3]. Wagner
et al [20] emphasized that a successful disease management
program should include a strong focus on patient information and
self-management (so that patients and their families acquire the
skills they need for their self-management) and effective commu-
nications, both among caregivers and between caregivers and
patients. Disease management programs (DMPs) can improve
health: they have proved successful in increasing health care
providers’ compliance with guidelines [30], and in improving
patients’ disease control in conditions such as diabetes [31,32].
The economic efficacy of DMPs is unclear, however [33]. Some
studies have reported net cost savings after adopting DMPs, and a
return on investment of $1.26 per $1.00 spent on disease
management services for patients with congestive heart failure
and diabetes [34].
The strength of our study lies in that it was conducted on an
unrestricted and unselected population. Our study has some
limitations too, however. First of all, not all the relevant socio-
economic factors were available in the database. One example
concerns the level of formal education, which could be a
confounding factor. On the other hand, the association between
age and education is unlikely to explain the reported U-shaped
trend of the association between age and outcome, since age and
education are linearly related [35]. These data could be biased,
however, due to an opportunistic sample of LHUs being enrolled
by the regional systems. There is also the risk of administrative
databases overestimating prevalence because of either a lack of
specificity of the case ascertainment algorithm or a failure to
differentiate co-morbidity overlaps in prescriptions. These impor-
tant methodological issues were addressed by a recent paper
demonstrating the consistency of the Valore database [11] - used
in the present study - with other sources of data, such as primary
care medical records and national surveys. Another limitation of
studies that make a secondary use of existing healthcare data
sources could lie in that they are based only on the prevalence of
diagnosed cases, from which the actual prevalence in the
population cannot be estimated [31]. Having said that, cases that
have yet to be diagnosed cannot be monitored, so this limitation
does not affect our results in terms of estimating the association
between monitoring practice and age group.
Finally, all drug-dispensing services and diagnostic or follow-up
tests funded by the national health system are recorded in our
database. Drugs purchased out-of-the counter or diagnostic and
follow-up tests paid out-of-pocket are not recorded, but there is no
evidence that use of such services is unevenly distributed across age
bands. On the other hand, the NHS database does not record
drug prescriptions for older people in long-term residential care,
because rest homes stock drugs without any reference to the
individual patients requiring them. The measurement bias due to
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this issue was assessed by taking into account the number of elderly
people (over 65 years old) in long-term residential care in the
Regions considered in this study according to the National Agency
for Regional Health Services data [36], weighted with the number
of chronic patients cases obtained by each region. This analysis
generated an estimated 4% data misclassification approximately
for drug prescriptions for the elderly age group. Such a bias
however could not affect the indicators relating to diagnostic and
instrumental tests because such prescriptions are always recorded
at the individual level.
In conclusion, creative solutions are needed to address the
escalating health care burden of chronic diseases. All chronic
conditions place heavy demands on health systems, and compa-
rable ways of organizing health care are similarly effective
regardless of the biomedical etiology involved [3]. Adopting
evidence-based approaches can make health care systems more
coherent and efficient, and provide a means for improving quality
across a range of chronic health problems, as well as ensuring that
primary health care really is a service that comes as close as
possible to where people live and work, with a level of care that
ensures fewer health disparities across population subgroups
(including those related to age) [37]. More action is still needed
to promote a proactive, integrated approach to chronic care
capable of involving chronic patients in all the seasons of their life.
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